Business Context and Reporting Period
Cocrystal Pharma, Inc. (COCP), a Delaware corporation, filed this Form 8-K on October 30, 2019. The report details a material definitive agreement regarding the company's equity distribution program.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or margins. The only financial data disclosed relates to the equity distribution agreement:
- Revised Offering Cap: $6,000,000
- Amount Raised to Date: $351,576
- Remaining Capacity: Approximately $5,648,424
Material Changes
On October 30, 2019, the Company amended and restated its Equity Distribution Agreement with A.G.P./Alliance Global Partners. The primary change was a reduction in the maximum aggregate amount of common stock that may be sold under the agreement from $10,000,000 to $6,000,000. This new cap is inclusive of the $351,576 already raised under the original agreement.
Outlook, Risks, and Management Commentary
The filing states that the agreement allows for the offer and sale of common stock pursuant to an effective Registration Statement on Form S-3. The Company notes that the representations and warranties in the agreement were made solely for the benefit of the parties and should not be relied upon as characterizations of the Company's actual condition. No specific guidance, risk factors, or unusual items beyond the amendment of the distribution agreement were disclosed in this report.
Investor Verification Checklist
- Verify the current market price of COCP common stock to assess the potential dilution from the remaining $5.6 million offering capacity.
- Review the full text of the Amended and Restated Equity Distribution Agreement (Exhibit 1.1) for specific terms regarding pricing, commissions, and termination rights.
- Confirm the Company's current cash position and burn rate to understand the necessity of the reduced offering cap.
- Check subsequent filings to determine if the Company has elected to terminate the agreement or if the full $6,000,000 was utilized.